An observational cross sectional cohort study to estimate the frequency of hepatitis E virus (HEV) infection in neurological disease of inflammatory/ immune mediated origin and ischemic stroke

An observational cross sectional cohort study to estimate the frequency of hepatitis E virus (HEV) infection in neurological disease of inflammatory/ immune mediated origin and ischemic stroke - Hepatitis E virus infection and neurological diseases

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON42390

Enrollment

100

Registered

2015-10-08

Start date

2015-11-09

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post infectious nervous system diseases post-infectious neurological diseases

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Participant is willing and able to give informed consent for participation in the study. Male or Female, aged 18 years or above. Diagnosed with an (sub)acute post-infectious/ immune-mediated neurological disorder or ischemic stroke Participants will have blood drawn for standard clinical care.

Exclusion criteria

Exclusion criteria: -Not willing and able to give informed consent

Design outcomes

Secondary

Measure	Time frame
To describe in detail the phenotypes of neurological illness of patients with a recent HEV infection.	—

Primary

Measure	Time frame
The number of HEV positive neurological patients (HEV PCR positive and/or IgM positive.	—

Countries

Netherlands

Outcome results